BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18849013)

  • 1. Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.
    Lang K; Lines LM; Lee DW; Korn JR; Earle CC; Menzin J
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):198-204. PubMed ID: 18849013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
    Etzioni R; Ramsey SD; Berry K; Brown M
    Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer.
    Ramsey SD; Berry K; Etzioni R
    Am J Gastroenterol; 2002 Feb; 97(2):440-5. PubMed ID: 11866285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient time costs associated with cancer care.
    Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
    J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data.
    Lang K; Menzin J; Earle CC; Jacobson J; Hsu MA
    Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1269-75. PubMed ID: 15545580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of patients with colorectal carcinoma under care in the U.S.
    Mariotto A; Warren JL; Knopf KB; Feuer EJ
    Cancer; 2003 Sep; 98(6):1253-61. PubMed ID: 12973850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of detection and treatment on lifetime medical costs for patients with precancerous polyps and colorectal cancer.
    Howard DH; Tangka FK; Seeff LC; Richardson LC; Ekwueme DU
    Health Econ; 2009 Dec; 18(12):1381-93. PubMed ID: 19142856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projections of the costs associated with colorectal cancer care in the United States, 2000-2020.
    Yabroff KR; Mariotto AB; Feuer E; Brown ML
    Health Econ; 2008 Aug; 17(8):947-59. PubMed ID: 17910108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland.
    Delcò F; Egger R; Bauerfeind P; Beglinger C
    Aliment Pharmacol Ther; 2005 Mar; 21(5):615-22. PubMed ID: 15740546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
    Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
    Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer screening differential costs for younger versus older Americans.
    Ladabaum U; Phillips KA
    Am J Prev Med; 2006 May; 30(5):378-84. PubMed ID: 16627125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer.
    Segelman J; Singnomklao T; Hellborg H; Martling A
    Colorectal Dis; 2009 Sep; 11(7):768-74. PubMed ID: 18662241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between colorectal cancer and urologic cancers.
    Calderwood AH; Huo D; Rubin DT
    Arch Intern Med; 2008 May; 168(9):1003-9. PubMed ID: 18474765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal carcinoma: correlation between age, gender and subsite distribution.
    Efremidou EI; Liratzopoulos N; Papageorgiou SM; Romanidis K; Tourlis T; Kouklakis G; Manolas KJ
    Chirurgia (Bucur); 2008; 103(6):659-63. PubMed ID: 19274910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.
    Seidler AM; Pennie ML; Veledar E; Culler SD; Chen SC
    Arch Dermatol; 2010 Mar; 146(3):249-56. PubMed ID: 20231494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimates of the lifetime direct costs of treatment for metastatic breast cancer.
    Berkowitz N; Gupta S; Silberman G
    Value Health; 2000; 3(1):23-30. PubMed ID: 16464178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000-2020.
    Mariotto AB; Yabroff KR; Feuer EJ; De Angelis R; Brown M
    Cancer Causes Control; 2006 Dec; 17(10):1215-26. PubMed ID: 17111252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifetime costs of colon and rectal cancer management in Canada.
    Maroun J; Ng E; Berthelot JM; Le Petit C; Dahrouge S; Flanagan WM; Walker H; Evans WK
    Chronic Dis Can; 2003; 24(4):91-101. PubMed ID: 14733758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.